BioCatalystWatch
ALLOWorkspace / ALLO / OverviewCompany library
Allogene Therapeutics, Inc. logo

Allogene Therapeutics, Inc.

Allogene Therapeutics, Inc. (ALLO)

Website

Price
Market cap
Next catalystExpected 2027ALLO-329 · Phase 1 dataCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

ALLO-329

CD19 × CD70

PreINDP1P2P3FilingApproved
Upcoming / outlook

Cema-cel

CD19

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

ALLO-329

CD19 × CD70

PreINDP1P2P3FilingApproved
Upcoming / outlook

Cema-cel

CD19

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Other pipelines

ALLO-316

CD70

PreINDP1P2P3FilingApproved
BCMA/CD70 dual CAR T cells

BCMA × CD70

PreINDP1P2P3FilingApproved
ALLO-182

CLDN18.2

PreINDP1P2P3FilingApproved

ALLO-213

DLL3

PreINDP1P2P3FilingApproved
ALLO-819

FLT3

PreINDP1P2P3FilingApproved

History / paused

Cema-cel

CD19

PreINDP1P2P3FilingApproved
Cema-cel

CD19

PreINDP1P2P3FilingApproved

CD52

PreINDP1P2P3FilingApproved

CD52

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ALLO PR & News

PR & News

ALLO SEC archive